Use of extracorporeal albumin dialysis for erythropoietic protoporphyria

Liver Transplantation

Volumn 13, Issue 5, 2007, Pages 639-640

  McGuire, Brendan M ^a   Bloomer, Joseph R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FERROCHELATASE; HEMATIN; HEME; IRON; PROTOPORPHYRIN;

ALBUMIN DIALYSIS; ALLELE; CHOLESTASIS; EDITORIAL; ENZYME ACTIVITY; ENZYME DEFICIENCY; ERYTHROPOIETIC PROTOPORPHYRIA; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; GENETIC POLYMORPHISM; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL LITERATURE; NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; TREATMENT INDICATION; TREATMENT OUTCOME; WILSON DISEASE;

HUMANS; PROTOPORPHYRIA, ERYTHROPOIETIC; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 34249099684     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21052     Document Type: Editorial

References (13)

1. Risheg H, Chen FP, Bloomer JR. Genotypic determinants in North American patients with erythropoietic protoporphyria. Mol Genet Metab 2003;80:196-206.
2. Doss MO, Frank M. Hepatobiliary implications and complications in protoporphyria: a 20-year study. Clin Biochem 1989;22:223-229.
3. Avner DL, Larsen R, Berenson MM. Inhibition of liver surface membrane, Na, K-adenosine triphosphatase, Mg-adenosine triphosphatase and 5′-nucleotidase activities by protoporphyrin. Observations in vitro and in the perfused rat liver. Gastroenterology 1983;85:700-706.
4. Meerman L, Koopen NR, Bloks V, vanGoor H, Havinga R, Wolthers BG, et al. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology 1999;117:696-705.
5. McGuire BM, Bonkovsky HL, Carithers RL Jr, Chung RT, Goldstein LI, Lake JR, et al. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl 2005; 11: 1590-1596.
6. Do KD, Banner EF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria. after orthotopic liver transplantation. Transplantation 2002;73: 469-472.
7. Rank JR, Straka JG, Weimer MK, Bossenmaier I, Taddeini L, Bloomer JR. Hematin therapy in late onset congenital erythropoietic porphyria. Br J Haematol 1990;75:617-618.
8. Meerman L, Verwer R, Slooff MJ, van Hattum J, Beukeveld GJ, Kleibeuker JH, et al. Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation 1994;57:155-158.
9. Bellmann R, Feistritzer C, Zoller H, Graziadei IW, Schwaig-Hofer H, Propst A, et al. Treatment of intractable pruritus in drug induced cholestasis with albumin dialysis: a report of two cases. ASAIO J 2004;50:387-91.
10. Manz T, Ochs A, Bisse E, Strey C, Grotz; W. Liver support - a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. Blood Purif 2003;21:232-236.
11. Hassanein T, Tofteng F, Brown RS Jr, McGuire BM, Lynch P, Mehta R, et al. Efficacy of albumin dialysis (MARS) in patients with cirrhosis and advanced grades of hepatic encephalopathy: a prospective, controlled, randomized multicenter trial. Hepatology 2004;(4 Suppl 1):726A.
12. Stefoni S, Coli L, Bolondi L, Donati G, Ruggeri G, Felician-Geli G, et al. Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients. Int J Artif Organs 2006; 29:207-218.
13. Eefsen M, Rasmussen A, Wulf HC, Brock A, Hansen BA. Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices, Liver Transpl 2007; 13:655-657.